MRK merck.com: Indikator likuiditas cepet

The dynamics of the intermediate coverage ratio demonstrate the financial stability of Merck & Co., Inc. (MRK), while 1.14 captures the current state of this parameter. The company is modernizing its wastewater treatment facilities and implementing eco-friendly packaging in compliance with strict waste regulations. Meanwhile, the business relies on the pricing power of Keytruda within the oncology segment. To refresh its portfolio, the holding company is actively acquiring promising biotech startups in the final stages of development.

Identifying stocks with maximum fundamental stability requires analyzing a company's ability to immediately settle its obligations. This indicator assesses the ratio of cash and accounts receivable to short-term debt, intentionally excluding illiquid inventory. For Merck & Co., Inc. (MRK), this is critical, as multi-year clinical trial expenditures demand high capital mobility. The trend of the final quick ratio demonstrates the balance between financial security and resource efficiency.